DL, O., E, P., N, B., A, F., P, L., CT, L., . . . JT, G. (2023). Correction to "Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069". Journal of medicinal chemistry, 66(1), 1082. https://doi.org/10.1021/acs.jmedchem.2c02002
Chicago Style (17th ed.) CitationDL, Orsi, et al. "Correction to "Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069"." Journal of Medicinal Chemistry 66, no. 1 (2023): 1082. https://doi.org/10.1021/acs.jmedchem.2c02002.
MLA (9th ed.) CitationDL, Orsi, et al. "Correction to "Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069"." Journal of Medicinal Chemistry, vol. 66, no. 1, 2023, p. 1082, https://doi.org/10.1021/acs.jmedchem.2c02002.